Nika Pharmaceuticals annual operating expenses
2020
2021
2022
2023
2024
2025
Nika Pharmaceuticals Operating Expenses Growth & History (NIKA)
Nika Pharmaceuticals's operating expenses was $76,398 for fiscal 2025.
View full Nika Pharmaceuticals company overviewNika Pharmaceuticals annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $76,398 | −$19,394 | −20.25% |
| 2024 | 2024-12-31 | $95,792 | $30,959 | +47.75% |
| 2023 | 2023-12-31 | $64,833 | −$3.1M | −97.96% |
| 2022 | 2022-12-31 | $3.2M | $3.2M | +21540.26% |
| 2021 | 2021-12-31 | $14,712 | $5,805 | +65.17% |
| 2020 | 2020-12-31 | $8,907 | — | — |
Nika Pharmaceuticals quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $19,694 | $1,313 | +7.14% |
| Q1 2026 | 2026-03-31 | $13,359 | $414 | +3.20% |
| Q4 2025 | 2025-12-31 | $37,090 | $18,074 | +95.05% |
| Q3 2025 | 2025-09-30 | $7,982 | −$385 | −4.60% |
| Q2 2025 | 2025-06-30 | $18,381 | −$4,076 | −18.15% |
| Q1 2025 | 2025-03-31 | $12,945 | −$33,007 | −71.83% |
| Q4 2024 | 2024-12-31 | $19,016 | −$5,961 | −23.87% |
| Q3 2024 | 2024-09-30 | $8,367 | −$1,776 | −17.51% |
| Q2 2024 | 2024-06-30 | $22,457 | $12,314 | +121.40% |
| Q1 2024 | 2024-03-31 | $45,952 | $26,382 | +134.81% |
| Q4 2023 | 2023-12-31 | $24,977 | $9,927 | +65.96% |
| Q3 2023 | 2023-09-30 | $10,143 | $3,804 | +60.01% |
| Q2 2023 | 2023-06-30 | $10,143 | −$3.1M | −99.68% |
| Q1 2023 | 2023-03-31 | $19,570 | $13,254 | +209.85% |
| Q4 2022 | 2022-12-31 | $15,050 | $11,750 | +356.06% |
| Q3 2022 | 2022-09-30 | $6,339 | $3,640 | +134.86% |
| Q2 2022 | 2022-06-30 | $3.2M | $3.2M | +106557.99% |
| Q1 2022 | 2022-03-31 | $6,316 | $562 | +9.77% |
| Q4 2021 | 2021-12-31 | $3,300 | — | — |
| Q3 2021 | 2021-09-30 | $2,699 | $2,539 | +1586.88% |
| Q2 2021 | 2021-06-30 | $2,959 | — | — |
| Q1 2021 | 2021-03-31 | $5,754 | — | — |
| Q3 2020 | 2020-09-30 | $160 | — | — |
Nika Pharmaceuticals operating expenses trends
Over the last five fiscal years, Nika Pharmaceuticals's operating expenses increased from $8,907 to $76,398, a change of $67,491. The latest reported quarter, Q2 2026, shows $19,694.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nika Pharmaceuticals source filings ↗